Financhill
Back

ESSA Pharma Stock Predictions

ESSA Pharma Stock Forecast

  • Is ESSA Pharma Stock Undervalued?
    The current ESSA Pharma [EPIX] share price is $4.93. The Score for EPIX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • EPIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ESSA Pharma Stock Go Up Next Year?

Data Unavailable

ESSA Pharma Stock Rating

Data Unavailable

ESSA Pharma Stock Price History

Is EPIX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Canada
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
essapharma.com

52-Week Data

52-Week High:
11.67
52-Week Low:
2.58

Prediction Charts

Market Cap:
218.71M
Price in USD:
4.93
Volume:
30.36K
Beta:
1.80

Technical Analysis

SMA50:
5.89
SMA100:
7.27
SMA200:
6.43
52-Wk Change:
82.59%

Stock Predictions

  • Is ESSA Pharma stock public?
    Yes, ESSA Pharma is a publicly traded company.
  • What is the ESSA Pharma stock quote today?
    The ESSA Pharma stock price is 4.93 USD today.
  • How to buy ESSA Pharma stock online?
    You can buy ESSA Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-12 5.72 5.14 5.83 5.14
Jun-13 5.12 4.63 5.18 4.60
Jun-14 4.64 5.37 5.39 4.59
Jun-17 5.48 4.90 5.48 4.66
Jun-18 4.90 4.66 5.22 4.60
Jun-20 4.72 4.98 5.15 4.62
Jun-21 4.94 4.90 5.15 4.72
Jun-24 4.97 4.85 4.99 4.72
Jun-25 4.90 4.82 4.95 4.74
Jun-26 4.75 4.92 5.00 4.65
Jun-27 5.00 5.18 5.25 4.91
Jun-28 5.18 5.23 5.26 4.89
Jul-1 5.22 5.12 5.30 4.78
Jul-2 4.75 4.93 4.99 4.66

ESSA Pharma Earnings

Data Unavailable

ESSA Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.29 per share.

* ESSA Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.